John Armitage’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134M Buy
+198,227
New +$118M 1.36% 20
2023
Q3
– Sell
-562,479
Closed -$293M – 27
2023
Q2
$293M Buy
562,479
+455,728
+427% +$246M 3.03% 15
2023
Q1
$61.5M Buy
+106,751
New +$60.2M 0.66% 23
2020
Q1
– Sell
-934,456
Closed -$304M – 35
2019
Q4
$304M Buy
934,456
+619,097
+196% +$188M 2.17% 20
2019
Q3
$91.9M Sell
315,359
-24,634
-7% -$7.05M 0.66% 30
2019
Q2
$100M Buy
+339,993
New +$93.6M 0.73% 28

Other funds holding TMO

John Armitage's TMO Position: Q3 2026 in Review

John Armitage opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 198,227 shares worth $134M. The stake represents 1.36% of the portfolio and ranks #20 among its holdings. This is a return to the name: John Armitage previously reported a position in TMO as recently as Q2 2023.

John Armitage first reported a position in TMO in Q2 2019 and has held it in 6 quarters since. The position peaked at $304M in Q4 2019. 2,797 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • John Armitage held 198,227 shares of Thermo Fisher Scientific worth $134M as of Q3 2026.
  • Thermo Fisher Scientific was a new John Armitage position in Q3 2026.
  • Thermo Fisher Scientific made up 1.36% of John Armitage's portfolio in Q3 2026, its #20 holding.
  • John Armitage first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 6 quarters since.
  • John Armitage's Thermo Fisher Scientific position peaked at $304M in Q4 2019.
  • 2,797 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Egerton Capital (UK)'s 13F filing for Q3 2026, filed 20 Oct 2026.